Mikhail Blagosklonny’s Milestone in Oncology, Aging and Immunity

Mikhail Blagosklonny is a professor of Oncology at Roswell Park Cancer Center who has done tremendous research that has resulted in good recommendations. His results treat cancer decisively, and he has made advances in the rejuvenation of the skin. Mikhail Blagosklonny went to First Pavlov State Medical University of St. Petersburg and acquired his MD in Internal Medicine. His Ph. D. is in Experimental Medicine and Cardiology that he got from the same University.

His career kicked off in the New York Medical College, Valhalla, New York, where he was an associate professor of medicine. He later went to work at Ordway Research Institute working as a Senior Research Scientist. At Roswell Park Center he was an Oncologist Professor, and that was in 2009. His service and dedication to helping solve the cancer menace have been clear all along, and he is very resourceful. The topics that he deals with are researching for targeted cancer therapies that do not harm healthy cells or mutate them, finding anti-aging drugs and most importantly biogerontology, that explains why people get old. Visit ResearchGate to keep up to date with Mikhail’s latest work.

With his time in the oncology field, he has risen to become an editor-in-chief of Oncotarget and Cell Cycle. Mikhail is a co-editor who does work in cancer biology and cancer therapy. He sits on the editorial board of the Cell Death and Differentiation, that comes up with the conclusion on TOR Signaling potential that he believes has an effect and role in cancer and aging. Mikhail has come up with a drug called Rapamycin that research has proved its effectiveness in curing cancer and aging. He has confidence on this drug, and he says it can boost low immunity for the old people.

Mikhail’s research is focused on Cellular and Molecular Biology and Clinical investigations. The studies and research are based on cell cycle, apoptosis, signal transduction, ontogenesis, tumor suppressors, drug resistance, selective protection, mitosis and anticancer therapeutics.

As a writer, ha has come up with different interesting pieces of articles and many journals. He has written on aging hyperfunction theory, cell cyclotherapy and the addition of more technology in chemotherapeutic engineering. Mikhail Blagosklonny is determined to solve the aging, immunosuppression and cancer problem in the world. His major discovery is that cancer and aging are close. Rapamycin is going to be the cure for Mikhail Blagosklonnyancer.

He has 300 articles that he has written overtime during his research. Journals and book chapters are some of the works that he loves doing. Most of his work has been printed and published under his name. Mikhail is an associate editor in PLOS ONE, the American Journal of Pathology and the International Journal of Cancer. His efforts and continued commitment have enabled him to come up with a lot of achievements that will be used by the people in the world. His findings can be further improved by future generations who will advance them to come up with solutions for specific problems. Follow Mikhail on Google Scholar